David Kerr’s 8-Year-Old Daughter Interviews Him About Life as a Cancer Doctor
Pope Leo XIV to Undergo Surgery to Remove Early-Detected Lung Nodule
15 Posts Not To Miss From DCLung26
10 Must-Read Posts In GU Oncology This Week
Small-Molecule Inhibitors in NSCLC: A 2026 Practical Guide to Drug Interactions and Toxicity
Sri Navaratnam Named Candidate for UICC Board of Directors 2026–2028
Michail Ignatiadis: Grateful for Hosting Session on Metastatic Breast Cancer at MAMMÔ 2026
Sanofi Foundation Marks Milestone in Global Humanitarian Action
OncoDaily IO is the dedicated immuno-oncology platform of OncoDaily, focused on the rapidly evolving science and clinical practice of cancer immunotherapy. It covers the full spectrum of immuno-oncology, including immune checkpoint blockade, cellular therapies, therapeutic cancer vaccines, antibody-based strategies, oncolytic viruses, next-generation immunomodulatory approaches, tumor microenvironment, immune biomarkers, neoantigens, treatment response and resistance, and personalized immunotherapy. Through OncoDaily IO, readers can follow the latest clinical trials, pivotal studies, translational research, regulatory decisions, emerging therapies, major congress highlights, and interviews with leading international experts advancing cancer prevention, control, and treatment through immunotherapy.
